Unicycive Therapeutics (UNCY) Payables (2020 - 2026)
Unicycive Therapeutics posted quarterly Payables of $1.1 million for Q1 2026, down 8.87% year-on-year from $1.3 million in Q1 2025, and up 197.65% on a QoQ basis from $383000.0 in Q4 2025.
Unicycive Therapeutics (UNCY) has 7 years of Payables data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 8.87% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 8.87% YoY), and the FY2025 full-year result was $383000.0, down 63.8% from the prior year.
- Payables for Q1 2026 stood at $1.1 million, up from $383000.0 in the prior quarter.
- Across five years, Payables topped out at $2.0 million in Q4 2023 and bottomed at $383000.0 in Q4 2025.
- The 5-year median for Payables is $800000.0 (2022), against an average of $926705.9.
- Peak annual rise in Payables reached 1532.65% in 2022, while the deepest fall reached 78.99% in 2022.
- A 5-year view of Payables shows it stood at $846000.0 in 2022, then surged by 136.41% to $2.0 million in 2023, then plunged by 47.1% to $1.1 million in 2024, then tumbled by 63.8% to $383000.0 in 2025, then soared by 197.65% to $1.1 million in 2026.
- The last three Payables figures came in at $1.1 million (Q1 2026), $383000.0 (Q4 2025), and $717000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 383,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Jun 30, 2025 | 708,000.00 |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 519,000.00 |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 990,000.00 |
| Jun 30, 2023 | 503,000.00 |
| Mar 31, 2023 | 790,000.00 |
| Dec 31, 2022 | 846,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 747,000.00 |
| Mar 31, 2022 | 589,000.00 |
| Dec 31, 2021 | 742,000.00 |
| Sep 30, 2021 | 49,000.00 |
| Jun 30, 2021 | 3.56 Mn |
| Dec 31, 2020 | 1.71 Mn |